PMID: 9160017May 1, 1997Paper

An investigation of the hospital charges related to the treatment of endophthalmitis in the Endophthalmitis Vitrectomy Study

Ophthalmology
S R WisniewskiB H Doft

Abstract

The purpose of the study is to assess the hospital charges associated with the treatment of endophthalmitis using a sample of patients from the Endophthalmitis Vitrectomy Study (EVS). The Endophthalmitis Vitrectomy Study was a multicenter, randomized clinical trial with a two-by-two factorial design to compare immediate pars plana vitrectomy to tap-biopsy and to compare the use of systemic antibiotics (intravenous) to no intravenous antibiotics in the management of postoperative endophthalmitis. Hospital charge data were collected retrospectively from 129 patients from the 4 clinical centers participating in this ancillary study. This represents 31% of the total Endophthalmitis Vitrectomy Study population. An analysis of variance was used to compare hospital charges across center and treatment. A charge-effectiveness analysis compared measures the effectiveness across treatment groups. The annual savings of hospital charges in the United States was estimated for a range of annual incidence rates of endophthalmitis. The use of intravenous antibiotics significantly increased hospital charges. Patients undergoing vitrectomy had significantly higher hospital charges than did patients undergoing tap-biopsy. The most charge-effective...Continue Reading

Associated Clinical Trials

References

Jun 1, 1984·Controlled Clinical Trials·M F Drummond, G L Stoddart
Jan 1, 1982·Annals of Internal Medicine·S A Finkler

❮ Previous
Next ❯

Citations

May 1, 1997·Ophthalmology·D W Parke
Dec 4, 2004·International Ophthalmology Clinics·Harry W FlynnDennis P Han
Dec 12, 2002·Retina·Destry J SulkesWilliam J Feuer
Sep 30, 2004·American Journal of Infection Control·Tanawat FongsreSilom Jamulitrat
Nov 26, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Elena NicodPanos Kanavos
Jul 26, 2011·Journal of Cataract and Refractive Surgery·Mark PackerUNKNOWN ASCRS Cataract Clinical Committee
Oct 30, 2004·Seminars in Ophthalmology·Taraprasad DasUNKNOWN Hyderabad Endophthalmitis Research Group
Dec 30, 2009·Applied Health Economics and Health Policy·Xavier ColinLaurent Kodjikian
Feb 27, 2007·Ophthalmology·Jordana K SchmierAlan L Robin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.